loadpatents
name:-0.042870044708252
name:-0.0098919868469238
name:-0.0019850730895996
Cheng; Seng Patent Filings

Cheng; Seng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheng; Seng.The latest application filed is for "inhibitors of glucosylceramide synthase".

Company Profile
1.7.22
  • Cheng; Seng - Bridgewater NJ
  • CHENG; Seng - Natick MA
  • Cheng; Seng - Framingham MA
  • Cheng; Seng - Bridgwater NJ US
  • Cheng, Seng - Wellesley MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gene therapy for lysosomal storage diseases
Grant 11,369,693 - Dodge , et al. June 28, 2
2022-06-28
Inhibitors Of Glucosylceramide Synthase
App 20210393590 - LIU; Hanlan ;   et al.
2021-12-23
Inhibitors Of T-cell Activation
App 20210380686 - Zhu; Yunxiang ;   et al.
2021-12-09
Glucosylceramide Synthase Inhibitors
App 20210261557 - BOURQUE; Elyse ;   et al.
2021-08-26
Inhibitors of T-cell activation
Grant 11,028,170 - Zhu , et al. June 8, 2
2021-06-08
Glucosylceramide Synthase Inhibitors
App 20200048266 - BOURQUE; Elyse ;   et al.
2020-02-13
Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy
Grant 10,111,962 - Leger , et al. October 30, 2
2018-10-30
Inhibitors Of T-cell Activation
App 20180030134 - Zhu; Yunxiang ;   et al.
2018-02-01
Inhibitors of T-cell activation
Grant 9,834,604 - Zhu , et al. December 5, 2
2017-12-05
Glucosylceramide Synthase Inhibitors
App 20160207933 - BOURQUE; Elyse ;   et al.
2016-07-21
Inhibitor Of Glucosylceramide Synthase
App 20160166542 - Liu; Hanlan ;   et al.
2016-06-16
Amorphous And A Crystalline Form Of Genz 112638 Hemitartrate As Inhibitor Of Glucosylceramide Synthase
App 20160120842 - Liu; Hanlan ;   et al.
2016-05-05
Compositions And Methods For Treating Proteinopathies
App 20150284472 - Sardi; Sergio Pablo ;   et al.
2015-10-08
Peptide-linked Morpholino Antisense Oligonucleotides For Treatment Of Myotonic Dystrophy
App 20150238627 - Leger; Andrew ;   et al.
2015-08-27
Gene Therapy For Lysosomal Storage Diseases
App 20150151007 - DODGE; James ;   et al.
2015-06-04
Glucosylceramide Synthase Inhibitors
App 20140371460 - BOURQUE; Elyse ;   et al.
2014-12-18
Inhibitors Of T-cell Activation
App 20140348832 - Zhu; Yunxiang ;   et al.
2014-11-27
Glucosylceramide Synthase Inhibitors
App 20140255381 - BOURQUE; Elyse ;   et al.
2014-09-11
Gene therapy for lysosomal storage diseases
Grant 8,796,236 - Dodge , et al. August 5, 2
2014-08-05
Amorphous And A Crystalline Form Of Genz 112638 Hemitartrate As Inhibitor Of Glucosylceramide Synthase
App 20130137743 - Liu; Hanlan ;   et al.
2013-05-30
Gene Therapy For Lysosomal Storage Diseases
App 20100173979 - DODGE; James ;   et al.
2010-07-08
Gene Therapy For Niemann-pick Disease Type A
App 20090117156 - Passini; Marco A. ;   et al.
2009-05-07
Genetic modification of the lung as a portal for gene delivery
App 20040110709 - Li, Chester ;   et al.
2004-06-10
Genetic modification of the lung as a portal for gene delivery
App 20010036454 - Li, Chester ;   et al.
2001-11-01
Methods for treatment of lysosomal storage diseases
App 20010031741 - Ziegler, Robin ;   et al.
2001-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed